| Literature DB >> 35453736 |
Ivo Vieira de Sousa Neto1,2, Dahan da Cunha Nascimento3, Jonato Prestes3, Eduardo Fernandes da Fonseca3, Rodrigo Souza Celes3, Nicholas Rolnick4, Yuri Gustavo de Sousa Barbalho2, Alessandro de Oliveira Silva5, Marina Morato Stival2,6, Luciano Ramos de Lima6, Silvana Schwerz Funghetto2,6.
Abstract
This study aimed to evaluate the time course and responsiveness of plasma interleukin-6 (IL-6) and creatine kinase (CK) levels following acute eccentric resistance exercise in sedentary obese older women with a different muscle quality index (MQI). Eighty-eight participants (69.4 ± 6.06 years) completed an acute eccentric resistance exercise (7 sets of 10 repetitions at 110% of 10-repetition maximum with 3 min rest interval). Participants were divided into two groups: high or low MQI according to 50th percentile cut-off. The responsiveness was based on minimal clinical important difference. There were no differences between groups and time on IL-6 and CK levels (p > 0.05). However, the high MQI group displayed a lower proportion of low responders (1 for laboratory and 2 for field-based vs. 5 and 4) and a higher proportion of high responders for IL-6 (7 for laboratory and 6 for field-based vs. 4 and 5) compared to low MQI group. In addition, the high MQI group showed a higher proportion of high responders for CK (11 for laboratory and 9 for field-based vs. 6 and 6) compared to low MQI. A prior MQI screening can provide feedback to understand the magnitude response. Individual responsiveness should be taken into consideration for maximizing eccentric exercise prescription.Entities:
Keywords: cytokines; eccentric training; muscle; physical activity; responders
Year: 2022 PMID: 35453736 PMCID: PMC9026080 DOI: 10.3390/biology11040537
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Laboratory muscle quality participants characteristics.
| Low MQI | High MQI |
| |||
|---|---|---|---|---|---|
| Age, Years | 68.55 ± 6.20 | 70.41 ± 5.92 | 0.51 | ||
| Body mass index, kg/m2 | 27.71 ± 5.03 | 27.75 ± 4.52 | 0.97 | ||
| Body fat, % | 41.47 ± 6.16 | 41.42 ± 5.18 | 0.96 | ||
| Upper body muscle mass, kg | 3.71 ± 0.62 | 3.87 ± 0.56 | 0.21 | ||
| Lower body muscle mass, kg | 11.04 ± 1.40 | 11.17 ± 1.28 | 0.64 | ||
| Appendicular muscle mass, kg | 14.75 ± 1.91 | 15.04 ± 1.60 | 0.44 | ||
| Body mass, kg | 64.44 ± 12.85 | 64.95 ± 11.47 | 0.84 | ||
| Height, m | 1.52 ± 0.06 | 1.52 ± 0.05 | 0.69 | ||
| Laboratory muscle quality index | 3.64 ± 0.60 | 5.16 ± 0.64 * | 0.001 | ||
| 10 RM leg extension, kg | 30.19 ± 6.19 | 43.20 ± 6.78 * | 0.001 | ||
| 1 RM leg extension, kg | 40.27 ± 8.26 | 57.62 ± 9.04 * | 0.001 | ||
| Creatine kinase, U/L | 91.52 ± 41.86 | 106.18 ± 49.32 | 0.13 | ||
| Total cholesterol, mg·dL−1 | 203.18 ± 31.06 | 210.57 ± 45.88 | 0.37 | ||
| Triglycerides, mg·dL−1 | 144.09 ± 68.92 | 142.33 ± 72.58 | 0.90 | ||
| High-density lipoprotein, mg·dL−1 | 46.95 ± 10.14 | 48.83 ± 12.69 | 0.44 | ||
| Low-density lipoprotein, mg·dL−1 | 127.41 ± 28.25 | 136.18 ± 36.21 | 0.20 | ||
| Very low-density lipoprotein, mg·dL−1 | 28.81 ± 13.80 | 27.19 ± 11.08 | 0.54 | ||
| Uric acid, mg·dL−1 | 4.50 ± 1.28 | 4.79 ± 1.96 | 0.41 | ||
| Glycemia, mg·dL−1 | 103.72 ± 37.05 | 91.60 ± 10.47 * | 0.04 | ||
| Urea, mg·dL−1 | 34.67 ± 7.87 | 35.73 ± 10.70 | 0.59 | ||
| Interleukin-6, pg/mL | 4.48 ± 3.44 | 4.61 ± 7.48 | 0.93 | ||
| Creatine Kinase, U/L | 91.52 ± 41.89 | 106.18 ± 49.32 | 0.13 | ||
| Low MQI | High MQI |
| |||
| Yes | No | Yes | No | ||
| Hypertension, % | 26.1 | 23.9 | 28.4 | 21.6 | 0.83 |
| Diabetes, % | 5.7 | 44.3 | 1.1 | 48.9 | 0.20 |
Note: Values are expressed as mean (standard deviation) or percentage. MQI, muscle quality index; * p < 0.05 low MQI vs. high MQI.
Field muscle quality participant characteristics.
| Low MQI | High MQI |
| |||
|---|---|---|---|---|---|
| Age, Years | 69.05 ± 6.10 | 69.91 ± 6.14 | 0.510 | ||
| Body mass index, kg/m2 | 29.22 ± 4.98 | 26.24 ± 4.06 * | 0.003 | ||
| Body fat, % | 43.02 ± 5.61 | 39.87 ± 5.31 * | 0.008 | ||
| Upper body muscle mass, kg | 3.76 ± 0.65 | 3.81 ± 0.53 | 0.70 | ||
| Lower body muscle mass, kg | 11.01 ± 1.36 | 11.20 ± 1.32 | 0.51 | ||
| Appendicular muscle mass, kg | 14.78 ± 1.86 | 15.02 ± 1.66 | 0.53 | ||
| Body mass, kg | 67.20 ± 13.48 | 62.18 ± 10.10 | 0.051 | ||
| Height, m | 1.51 ± 0.06 | 1.53 ± 0.05 | 0.052 | ||
| Field-based muscle quality index | 1.42 ± 0.25 | 2.16 ± 0.33 * | 0.001 | ||
| 10 RM leg extension, kg | 31.05 ± 6.78 | 42.34 ± 7.73 * | 0.001 | ||
| 1 RM leg extension, kg | 41.41 ± 9.04 | 56.47 ± 10.31 * | 0.001 | ||
| Creatine kinase, U/L | 95.07 ± 39.82 | 102.64 ± 51.79 | 0.44 | ||
| Total cholesterol, mg·dL−1 | 203.04 ± 31.64 | 210.70 ± 45.46 | 0.36 | ||
| Triglycerides, mg·dL−1 | 138.93 ± 51.59 | 147.49 ± 85.55 | 0.57 | ||
| High-density lipoprotein, mg·dL−1 | 47.90 ± 11.05 | 48.87 ± 11.98 | 0.99 | ||
| Low-density lipoprotein, mg·dL−1 | 127.35 ± 30.25 | 136.23 ± 34.53 | 0.20 | ||
| Very low-density lipoprotein, mg·dL−1 | 27.77 ± 10.31 | 28.23 ± 14.43 | 0.86 | ||
| Uric acid, mg·dL−1 | 4.76 ± 1.34 | 4.52 ± 1.93 | 0.50 | ||
| Glycemia, mg·dL−1 | 103.29 ± 36.73 | 91.03 ± 10.88 * | 0.024 | ||
| Urea, mg·dL−1 | 35.24 ± 6.77 | 35.15 ± 11.46 | 0.96 | ||
| Interleukin-6, pg/mL | 4.13 ± 3.36 | 5.02 ± 7.70 | 0.44 | ||
| Creatine Kinase, U/L | 95.07 ± 39.82 | 102.64 ± 51.79 | 0.44 | ||
| Low MQI | High MQI |
| |||
| Yes | No | Yes | No | ||
| Hypertension, % | 27.3 | 22.7 | 20.5 | 29.5 | 0.28 |
| Diabetes, % | 6.8 | 43.2 | 0.0 | 50 | 0.026 |
Note: Values are expressed as mean (standard deviation) or percentage. MQI, muscle quality index; * p < 0.05 Low MQI vs. High MQI.
Figure 1Schematic study design and timeline used to examine the time course of interleukin-6 (IL-6) and creatine kinase (CK) levels following acute eccentric resistance exercise in sedentary obese older women with different muscle quality index (MQI).
Figure 2Interleukin 6 (IL-6) levels in blood circulation (mean ± SE) after an acute bout of eccentric exercise in older obese women with low and high muscle quality. (A) Laboratory IL-6 levels; (B) AUC laboratory IL-6 levels; (C) field-based IL-6 levels; (D) AUC field-based IL-6 levels.
Figure 3Creatine kinase (CK) levels in blood circulation (mean ± SE) after an acute bout of eccentric exercise in older obese women with low and high muscle quality. (A) Laboratory CK levels; (B) AUC laboratory CK levels; (C) field-based CK levels; (D) AUC field-based CK levels.
Figure 4Responsiveness for the interleukin 6 (IL-6) levels based on minimal clinical important difference (MCID). (A) Laboratory IL-6 levels; (B) field-based IL-6 levels.
Figure 5Responsiveness for creatine kinase (CK) levels based on minimal clinical important difference (MCID). (A) Laboratory CK levels; (B) field-based CK levels.
Values of effect size for main effect of time.
| LMQI | HMQI | |
|---|---|---|
|
|
|
|
|
| ||
| IL-6, pg/ml | 0.073 (small) | 0.089 (small) |
| CK, U/L | 0.070 (small) | 0.076 (small) |
|
| ||
| IL-6, pg/ml | 0.044 (small) | 0.104 (small) |
| CK, U/L | 0.061 (small) | 0.091 (small) |
Note: f, effect size; IL-6, interleukin 6; LMQI, low muscle quality index; HMQI, high muscle quality index.
Figure 6Overview of main findings and hypothetical mechanism involved in high MQI group.